DeutschNewstral
Article
Star Tribune on 2022-05-02 21:46
FDA won't disqualify HCMC doctors from research over sedative studies
Related news
- Watchdog group calls on FDA to disqualify Hennepin Healthcare doctors, review board from clinical researchStar Tribune
- FDA says HCMC doctors kept ketamine study going after pledging to stopStar Tribune
- FDA: Hennepin Healthcare flouted patient safety rules in sedation studiesStar Tribune
- At HCMC, doctors pursue new way to treat opioid addictionStar Tribune
- Judge throws out patient's ketamine lawsuit against HCMCStar Tribune
GAO Report Regarding FDA-Ordered Postmarket Studiesjdsupra.com
FDA orders safety studies from scope manufacturersLA Times- After conflict of interest concerns, HCMC to sever agreement with Taser manufacturerStar Tribune
New Thrivent HQ to connect downtown, HCMCfinance-commerce.com- Attorneys: HCMC employees looked at George Floyd's private medical records without authorizationStar Tribune
Court revives doctors’ FDA ivermectin suitArkansas Online- HCMC remodel contract goes to Knutsonfinance-commerce.com
FDA proposes training doctors about prescribing drugsWBNS-10TV- HFDA Will Allow Short Studies of Virus Variantshamodia.com
- HCMC plans bigger expansion in downtown Minneapolisfinance-commerce.com
HCMC unveils renderings of $191M expansion (images)bizjournals.com- FDA lifts clinical hold on AstraZeneca cancer drug studiesbizjournals.com
- HCMC prints 3-D implant to repair fractured skull boneStar Tribune
- As it searches for new leader, HCMC faces huge challengesStar Tribune